My Notes

This is one of 500 SBU physicians affiliated providers practicing within 18 professional entities (specialty groups) that provide quality medical services from primary care to the most advanced specialty care for patients of all ages. These physicians and health care professionals are committed to excellence in service and leadership in clinical care for their patients. They treat patients, teach tomorrow's physicians, and lead research projects that keep them at the forefront of their specialty.

My Articles

(1)Parker RI and Gralnick HR: Energy dependent expression of platelet von-Willebrand factor on the surface of unstimulated and stimulated platelets. J Lab Clin Med 130:520-529, 1997. (2)Mahgoub N, Parker RI, Hosler MR, Close P, Shannon KM, Felix CA: RAS mutations in pediatric leukemias with MLL gene rearrangements. Genes Chromosomes and Cancer 21:270-275, 1998. (3)Parker RI, Siegal RS, Ratajczak M, Gewirtz AM: Deficient In Vitro megakaryocytopoiesis and decreased In Vivo platelet turnover in children and young adults with chronic thrombocy¬topenia. J Ped Hematol/Oncol 20:196-201,1998. (4)Felix CA, Hosler MR, Slater DJ, Parker RI, Masterson M, Whitlock JA, Nowell PC, Lange, BJ: MLL genomic breakpoint distribution within breakpoint cluster region in de novo leukemia in children. J Ped Hematol/Oncol 20:299-308, 1998. (5)Parker RI, Prakash D, Giugliano D, Mahan RA, Atlas M: A randomized double-blind cross-over placebo-controlled trial of intravenous ondansetron for the prevention of post-intrathecal chemotherapy induced vomiting in children. J Ped Hematol/Oncol 23:578-581, 2001. (6)Ancona K, Parker RI, Atlas M, Prakash D: A randomized trial of high dose methylprednisolone vs. IV-IgG for the treatment of acute ITP in children. J Pediatr Hematol/Oncol 24:540-544, 2002.